30 Mar 23
A small biotech company moved its product into clinical development and needed to complete a phase II study on limited resources before receiving further funding.
tranScrip provided clinical, regulatory, drug safety, and operational support along with internal staff training.
Phase II study completed on time and within budget. Operational systems successfully inspected by MHRA.
Get in touch to see how our senior cross-functional experts can help you reduce risk, protect value, and move forward with confidence.